Senior Director, Health Economics and Outcomes Research

Responsibilities

• Develop and own the global and US HEOR strategy aligned with clinical development and market access
• Build a fit-for-purpose HEOR roadmap including burden of illness, cost-of-illness, and RWE plans
• Design and oversee RWE studies, including natural history studies, chart reviews, and registries
• Lead development and validation of patient-reported outcomes (PROs) and clinical outcome assessments (COAs)
• Lead development of global value dossiers (GVDs), AMCP dossiers, and HTA submissions
• Build and maintain cost-effectiveness models and budget impact models
• Partner cross-functionally with Medical Affairs, Market Access, and Patient Advocacy
• Represent the company with payers, HTA bodies, academic partners, and KOLs

Requirements

• Advanced degree (PhD, PharmD, MD, MPH, MS) in health economics, epidemiology, or related field
• 10+ years of HEOR/RWE experience in biotech/pharma
• 5+ years in a leadership or strategic role
• Demonstrated success in pre-launch and launch activities
• Deep expertise in economic modeling, RWE methodologies, and PRO/COA development
• Experience in rare disease, autoimmune diseases, or high-cost specialty products
• Familiarity with US and ex-US pricing and reimbursement landscapes

About the Company

Vor is a biotech company focused on tackling autoimmune disease at its root. By advancing telitacicept, a dual BAFF/APRIL inhibitor, they aim to redefine the future of autoimmune care and change the course of disease for patients worldwide.